Media-OutReach Newswire New antibiotic drug developed by HKU Chemistry research team approved for clinical trials in humans
Media-OutReach Newswire M&L Healthcare's First MedTech Investment Receives FDA Approval Following Successful US Trials
Media-OutReach Newswire Immuno Cure Completed US$12M First Close of Series A Financing, led by AEF GBA Fund managed by Gobi Partners GBA
Media-OutReach Newswire Novel Chinese medicine for constipation developed by HKBU authorised by U.S. FDA for clinical trial
Media-OutReach Newswire Renowned Microbiologist Yuen Kwok-yung and Virologist David Ho initiate Global Pandemic Research Alliance
Media-OutReach Newswire Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
Media-OutReach Newswire Strategic Investment in BioMed by Human Health for Propelling Advancements in Gut Microbiome Based Health Management and Its Medical Application
Media-OutReach Newswire The United Laboratories International Holdings Limited Applies for the Clinical Trial of its Class 1 Innovative New Drug UBT251 Injection
Media-OutReach Newswire LiveSpo represents Vietnam, announces world's first spore probiotics in nasal spray form at the BIO International Convention
Media-OutReach Newswire Cedrus Group Signs Investment And Advisory Collaboration Agreement With Xiuzheng Pharmaceutical Group
Media-OutReach Newswire CIRC: The innovation and development of technology-led enterprises achieved the best business performance in history
Media-OutReach Newswire The Malaysia Healthcare Travel Council: Upholding Medical Innovations as a Cancer Care Centre of Excellence